| |
|
|
|
Amneal Pharmaceuticals Inc  
|
|
5.05 0.09 (0.02%) |
09-17 16:00 |
|
Open: |
4.99 |
Pre close: |
4.96 |
Target:
|
6.26
|
|
High: |
5.07 |
Low: |
4.9 |
Resistance:
|
5.36
5.77
|
|
Volume: |
2,621,551 |
Market Cap: |
751M |
Support:
|
4.69
3.90
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.00
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
5.24  |
Signal(12,26,9): |
0.03 |
|
MA(100): |
5.26 |
Stochastic Oscillator |
%K(14,3):
|
23.34 |
|
MA(250): |
5.13 |
%D(3): |
17.16 |
|
Average Volume(K) |
3-Month: |
5155742
|
52-Week |
High:
|
7.45 |
|
10-Days: |
679335 |
Low: |
3.76 |
|
RSI |
RSI(14):
|
47.11 |
Change(%): |
19.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.120 |
Return on Equity (ttm) |
-9.6 |
Shares Out. (M) |
148.72 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
1.9 |
Shares Float (M) |
95.30 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.55 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-1.1 |
% Held by Institutions |
70.34 |
|
Forward EPS |
-2.740 |
Gross Profit (p.s.) |
4.386 |
Shares Short (K) |
4530 |
|
Book Value (p.s.) |
2.170 |
EBITDA (p.s.) |
2.409 |
P/E |
-42.08 |
|
Sales Per Share |
13.381 |
Qtrly Earnings Growth |
-94.20 |
P/BV |
2.33 |
|
Profit Margin |
-0.87 |
Operating Cash Flow
(M) |
478.10 |
P/S |
0.38 |
|
Operating Margin |
6.31 |
Levered Free Cash Flow
(M) |
420.50 |
P/CF |
1.57 |
|
|
|
|
|
|
